Used in pharmaceutical research as a key intermediate in the synthesis of thrombin inhibitors. Shows potential in anticoagulant drug development due to its ability to selectively bind to serine proteases involved in blood coagulation. Also investigated for use in treatments of cardiovascular diseases where controlled blood clotting is critical. Its structure allows for high affinity interactions with enzyme active sites, making it valuable in designing potent and selective therapeutic agents.